RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD
Key facts
- Who runs it
- Beykoz University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Feb 2025
- Planned end
- 1 Sept 2025
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Psychoanalytic Psychotherapy
- Cognitive Behavioral Therapy (CBT)
- Record updated
- 18 February 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age between 18 and 65 years
- A confirmed diagnosis of Generalized Anxiety Disorder (GAD) according to DSM-5 criteria, with the diagnosis made within the past 2 years
- No participation in any form of psychotherapy during the past 6 months
- Ability and willingness to attend 12 weekly therapy sessions (50 minutes each) over the 3-month intervention period
- For participants receiving online sessions: access to a stable internet connection and the necessary technology
- Ability to understand and provide written informed consent
Who cannot take part
- Recent changes in psychotropic medication (i.e., medication changes within the past 3 months, unless on a stable dose)
- Presence of significant comorbid psychiatric disorders that could interfere with participation or assessment (e.g., bipolar disorder, psychotic disorders, substance use disorders, eating disorders)
- Severe medical or neurological conditions that may interfere with study participation or data interpretation
- Any condition that, in the opinion of the investigators, would compromise the safety or compliance of the participant in the study
- Current participation in another clinical trial or structured psychotherapy program
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is a randomized controlled trial designed to compare the effectiveness of two types of short-term psychotherapy-psychoanalytic therapy and Cognitive Behavioral Therapy (CBT)-in treating Generalized Anxiety Disorder (GAD). A total of 60 adult participants with a confirmed diagnosis of GAD will be enrolled and randomly assigned to one of three groups: one group will receive psychoanalytic therapy, a second group will receive CBT, and a third group will serve as a control (waiting list) group. Each treatment group will participate in 12 weekly sessions, with each session lasting 50 minutes.
Read full original descriptionShow less
In the psychoanalytic therapy group, therapy will follow a standardized framework based on core psychoanalytic principles such as exploring unconscious conflicts, transference, and resistance. While this approach is flexible, all therapists will be trained and calibrated to apply these core principles consistently. In contrast, the Cognitive Behavioral Therapy (CBT) group will receive a structured, manualized intervention specifically designed for Generalized Anxiety Disorder (GAD). The control group will not receive any active psychotherapy during the study period but will continue to receive any standard care they are already using.
The primary outcome of the study will be the change in anxiety symptoms measured by the Beck Anxiety Inventory (BAI) from before treatment to after the 12 sessions. Secondary outcomes will include measures of quality of life (using the World Health Organization Quality of Life Instrument [WHOQOL-BREF]), depressive symptoms (using the Beck Depression Inventory-II [BDI-II]), functional impairment (using the World Health Organization Disability Assessment Schedule II [WHODAS II]), the quality of the therapeutic relationship (using the Working Alliance Inventory [WAI]), and overall treatment satisfaction.
The study is designed to be completed within a six-month period: one month for recruitment, one month for baseline assessments and clinical checks, and three months for the intervention. Data will be collected at baseline and immediately after the intervention, with the goal of analyzing and publishing the results as soon as possible following treatment completion. This study has received ethical approval from the Üsküdar University Ethics Committee and is intended to inform future research on effective treatments for Generalized Anxiety Disorder (GAD).
The 3 groups in the trial
- Psychoanalytic TherapyTreatment being tested
Participants in this arm will receive short-term psychoanalytic therapy delivered via a standardized framework. Although the approach is not strictly manualized, a set of core principles (including exploration of unconscious conflicts, transference, and resistance) will guide therapy. The therapy will be administered in 12 weekly sessions, each lasting 50 minutes, by two of the study authors trained in this approach.
Treatment: Psychoanalytic Psychotherapy
- Cognitive Behavioral Therapy (CBT)Treatment being tested
Participants in this arm will receive a structured, manualized cognitive behavioral therapy (CBT) intervention specifically designed for the treatment of Generalized Anxiety Disorder (GAD). Therapy will consist of 12 weekly sessions, each 50 minutes in duration, delivered by two of the study authors with specialized CBT training.
- Control (Waiting List)No study treatment, for comparison
Participants in this arm will be placed on a waiting list for treatment. They will not receive any active psychotherapeutic intervention during the study period but may continue any standard care they are already receiving.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Randomized Controlled Trial Comparing Short-Term Psychoanalytic Therapy and Cognitive Behavioral Therapy for Generalized Anxiety Disorder
- Fit questions
- Built from NCT06831708, who can take part
- Record updated
- 18 February 2025